CapForce IBD 50 ETF
FFTY
83 hedge funds and large institutions have $80.6M invested in CapForce IBD 50 ETF in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 36 reducing their positions, and 21 closing their positions.
2% more call options, than puts
Call options by funds: $331K | Put options by funds: $325K
0% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 21
1% less funds holding
Funds holding: 84 → 83 (-1)
3.96% less ownership
Funds ownership: 27.51% → 23.55% (-4%)
47% less capital invested
Capital invested by funds: $153M → $80.6M (-$72.4M)
61% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 36
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.41M |
| 2 |
Jane Street
New York
|
+$1.92M |
| 3 |
BAAM
Baker Avenue Asset Management
San Francisco,
California
|
+$1.46M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.36M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$917K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.65M |
| 2 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$4.76M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4.73M |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$4.06M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$3.31M |
FFTY Hedge Fund Activity: Q4 2018 in Review
83 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q4 2018, worth a combined $80.6M — down 47% from $153M a quarter earlier.
Fund positioning in FFTY was balanced in Q4 2018: 21 funds opened new positions, 21 closed out, 14 added to existing stakes and 36 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $2.41M. The largest seller was UBS Group, cutting an estimated $8.65M.
- 83 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q4 2018, down from 84 in Q3 2018.
- Funds reported $80.6M of CapForce IBD 50 ETF stock for Q4 2018, down 47% quarter-over-quarter.
- 21 funds opened new CapForce IBD 50 ETF positions in Q4 2018 and 21 closed out, a net change of 0 holders.
- The largest CapForce IBD 50 ETF buyer in Q4 2018 was Tower Research Capital (TRC), an estimated $2.41M added.
- The largest CapForce IBD 50 ETF seller in Q4 2018 was UBS Group, an estimated $8.65M sold.
Based on aggregated 13F filings for Q4 2018.